Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation

JR Schriber(Stanford University), KG Blume(Stanford University), RS Negrin(Stanford University), NJ Chao(Stanford University), GD Long(Stanford University), KS Lucas(Stanford University), C. Kusnierz-Glaz(Stanford University), DK Tierney(Stanford University)

Blood

September 1, 1994

10.1182/blood.v84.5.1680.1680

Cited by 75

Related Papers

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.

|The Journal of Experimental Medicine|1991|623

Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy

|Blood|1993|284

Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy

|Blood|1996|209

Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells

|Blood|1995|127

Dynamic assessment of quality of life after autologous bone marrow transplantation

|Blood|1992|111